Amova Asset Management Americas Inc. Decreases Stake in BWX Technologies, Inc. $BWXT

Amova Asset Management Americas Inc. reduced its stake in shares of BWX Technologies, Inc. (NYSE:BWXT) by 6.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 252,490 shares of the technology company’s stock after selling 18,818 shares during the quarter. Amova Asset Management Americas Inc.’s holdings in BWX Technologies were worth $43,630,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Alkeon Capital Management LLC raised its stake in shares of BWX Technologies by 163.0% in the third quarter. Alkeon Capital Management LLC now owns 1,578,048 shares of the technology company’s stock worth $290,945,000 after purchasing an additional 978,000 shares during the last quarter. Invesco Ltd. boosted its position in BWX Technologies by 60.1% in the third quarter. Invesco Ltd. now owns 2,549,150 shares of the technology company’s stock valued at $469,987,000 after buying an additional 956,770 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in BWX Technologies in the 3rd quarter worth approximately $163,969,000. Select Equity Group L.P. acquired a new position in BWX Technologies in the 2nd quarter worth approximately $68,902,000. Finally, Orion Porfolio Solutions LLC raised its position in BWX Technologies by 1,353.1% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 363,757 shares of the technology company’s stock worth $52,403,000 after buying an additional 338,723 shares during the last quarter. 94.39% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other BWX Technologies news, CEO Rex D. Geveden sold 10,000 shares of BWX Technologies stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total transaction of $2,048,100.00. Following the completion of the sale, the chief executive officer directly owned 202,491 shares of the company’s stock, valued at $41,472,181.71. The trade was a 4.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $209.25, for a total value of $505,757.25. Following the completion of the transaction, the chief financial officer directly owned 6,884 shares of the company’s stock, valued at $1,440,477. This trade represents a 25.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

BWXT has been the topic of several recent research reports. Zacks Research downgraded shares of BWX Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Deutsche Bank Aktiengesellschaft raised shares of BWX Technologies from a “hold” rating to a “buy” rating and raised their target price for the stock from $205.00 to $255.00 in a report on Friday, May 15th. BTIG Research boosted their target price on shares of BWX Technologies from $225.00 to $235.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. Truist Financial upped their price target on shares of BWX Technologies from $205.00 to $212.00 and gave the company a “hold” rating in a report on Monday, May 11th. Finally, TD Securities assumed coverage on BWX Technologies in a research note on Thursday, March 12th. They set a “buy” rating and a $230.00 price objective for the company. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, BWX Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $228.00.

BWX Technologies Stock Up 0.7%

Shares of NYSE BWXT opened at $188.75 on Wednesday. The company’s 50-day simple moving average is $210.25 and its 200-day simple moving average is $199.84. BWX Technologies, Inc. has a 52-week low of $128.96 and a 52-week high of $241.82. The firm has a market cap of $17.29 billion, a price-to-earnings ratio of 50.47, a price-to-earnings-growth ratio of 3.09 and a beta of 0.73. The company has a quick ratio of 2.33, a current ratio of 2.40 and a debt-to-equity ratio of 1.58.

BWX Technologies (NYSE:BWXT) last issued its quarterly earnings data on Monday, May 4th. The technology company reported $1.12 EPS for the quarter, topping the consensus estimate of $0.92 by $0.20. BWX Technologies had a net margin of 10.20% and a return on equity of 31.33%. The firm had revenue of $860.22 million for the quarter, compared to analyst estimates of $837.47 million. During the same period in the prior year, the business posted $0.91 EPS. The business’s revenue for the quarter was up 26.1% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. Equities analysts predict that BWX Technologies, Inc. will post 4.71 EPS for the current fiscal year.

BWX Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 5th. Shareholders of record on Tuesday, May 19th were paid a $0.27 dividend. The ex-dividend date was Tuesday, May 19th. This represents a $1.08 dividend on an annualized basis and a yield of 0.6%. BWX Technologies’s dividend payout ratio (DPR) is currently 28.88%.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.